A new research method has elucidated cellular processes (involving mutated TP53 oncogene) that can convert a relatively benign myeloproliferative...
The interview was filmed in preparation for an article in Oncology Times @OncologyTimes BOSTON, MA—The risks of death from organ damage caused by...
Audio Journal of Oncology Podcast CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second Study Confirms Play Episode Pause Episode Mute/Unmute...
Audio Journal of Oncology Podcast Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per Cent Play Episode Pause Episode Mute/Unmute Episode...
Audio Journal of Oncology Podcast New Front Line Standard for Older Patients with Chronic Lymphocytic Leukemia Play Episode Pause Episode Mute/Unmute...
Audio Journal of Oncology Podcast Microbiome Diversity Key To Survival After Allogeneic Hematopoietic Cell Transplantation Play Episode Pause Episode...
Audio Journal of Oncology Reporting from 2018 annual meeting of the American Society of Hematology INTERVIEW WITH: John C. Byrd MD, Chief Medical...
Audio Journal of Hematology Ibrutinib: New Frontline Standard for Chronic Lymphocytic Leukemia? Play Episode Pause Episode Mute/Unmute Episode Rewind...
Audio Journal of Oncology Podcast Head and Neck Cancer Therapy De-Escalation: A “Salutary Lesson” Play Episode Pause Episode Mute/Unmute Episode...
Audio Journal of Oncology Podcast Which New Combination for Metastatic Renal Cell Cancer? Play Episode Pause Episode Mute/Unmute Episode Rewind 10...
Audio Journal of Oncology Podcast Two Drug Combination Doubled Kidney Cancer Progression Free Survival Play Episode Pause Episode Mute/Unmute Episode...
Audio Journal of Oncology Podcast ALK—Targeted Lung Cancer Drugs Benefited Real World Patients Play Episode Pause Episode Mute/Unmute Episode Rewind...